Daniel Diniz De Carvalho

This inventor holds 6 USPTO granted patents and 11 published patent applications, plus 1 CIPO patent. Top assignees: University Health Network, Sinai Health System. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel Diniz De Carvalho. Retrieved from https://idiyas.com/inventor/daniel-diniz-de-carvalho

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 11)

% Patents Active = 83.3

CIPO Patents = 1 (Patent Applications = 11)

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 9(Granted Patents)

Company Filing History:

6 out of 312

University Health Network

where one patent can have more than one assignee

Years Active: 2021-2026

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12649915 - METHODS OF CAPTURING CELL-FREE METHYLATED DNA AND USES OF SAME (2026-06-09),

2. 12592321 - Cancer detection and classification using methylome analysis (2026-03-31),

3. 12227737 - Cancer detection and classification using methylome analysis (2025-02-18),

4. 12031184 - Cancer detection and classification using methylome analysis (2024-07-09),

5. 11560558 - Methods of capturing cell-free methylated DNA and uses of same (2023-01-24),

6. 11078475 - Methods of capturing cell-free methylated DNA and uses of same (2021-08-03),

Title: The Innovative Contributions of Daniel Diniz De Carvalho

Introduction

Daniel Diniz De Carvalho is a notable inventor based in Toronto, Canada. He has made significant strides in the field of cancer detection and classification through innovative methodologies. With a total of 6 patents to his name, his work is paving the way for advancements in medical diagnostics.

Latest Patents

Among his latest patents, Daniel has developed methods for cancer detection and classification using methylome analysis. One of his patents describes a method of capturing cell-free methylated DNA from a sample containing less than 100 mg of cell-free DNA. This process involves library preparation for sequencing, the addition of methylated filler DNA, denaturation of the sample, and the capture of cell-free methylated DNA using a selective binder. Another patent outlines a method for detecting DNA from cancer cells in a subject. This includes providing a sample of cell-free DNA, library preparation, and sequencing the captured cell-free methylated DNA. The sequences are then compared to those from healthy and cancerous individuals to identify the presence of cancer cell DNA.

Career Highlights

Daniel has worked with prominent organizations such as Sinai Health System and University Health Network. His contributions in these institutions have been instrumental in advancing cancer research and diagnostics.

Collaborations

Daniel has collaborated with notable colleagues, including Shu Yi Shen and Rajat Singhania. Their combined expertise has further enhanced the impact of his research.

Conclusion

Daniel Diniz De Carvalho's innovative work in cancer detection and classification exemplifies the importance of research in improving medical diagnostics. His patents and collaborations reflect a commitment to advancing healthcare through technology.

Profile summary based on public USPTO records.